•
Sep 30, 2013

PTC Therapeutics Q3 2013 Earnings Report

Total Revenue
$16.3M
Previous year: $6.04M
+169.6%
EPS
-$0.19
Previous year: $49.1
-100.4%
Cash and Equivalents
$24M
Previous year: $14.5M
+66.2%
Total Assets
$167M

PTC Therapeutics

PTC Therapeutics